Kosicka-Noworzyń K - Search Results

1

Pharmacokinetics of Nivolumab and Erythropoietin in a Rat Model of Diet-Induced Obesity.

Sheng YH, Park C, Chong YE, Yohn C, Siemiątkowska A, Kosicka-Noworzyń K, Kaur A, Sapra K, Brunetti L, Kagan L. Sheng YH, et al. Among authors: kosicka noworzyn k. Pharm Res. 2025 Jan 23. doi: 10.1007/s11095-025-03819-1. Online ahead of print. Pharm Res. 2025. PMID: 39849218

2

A Novel Liquid Chromatography-Tandem Mass Spectrometry Method to Quantify Tryptophan and Its Major Metabolites in Serum to Support Biomarker Studies in Patients with Cancer Undergoing Immunotherapy.

Siemiątkowska A, Kuźnar-Kamińska B, Kosicka-Noworzyń K, Nowaczewska K, Winiarska H, Popiołek D, Kamiński F, Główka FK. Siemiątkowska A, et al. Among authors: kosicka noworzyn k. Molecules. 2024 Dec 31;30(1):121. doi: 10.3390/molecules30010121. Molecules. 2024. PMID: 39795179 Free PMC article.

3

Obesity-related drug transporter expression alterations in human liver and kidneys.

Kosicka-Noworzyń K, Romaniuk-Drapała A, Sheng YH, Yohn C, Brunetti L, Kagan L. Kosicka-Noworzyń K, et al. Pharmacol Rep. 2024 Dec;76(6):1429-1442. doi: 10.1007/s43440-024-00665-7. Epub 2024 Oct 16. Pharmacol Rep. 2024. PMID: 39412582 Free PMC article.

4

A validated LC-MS/MS method for simultaneous quantitation of piperacillin, cefazolin, and cefoxitin in rat plasma and twelve tissues.

Sheng YH, Siemiątkowska A, Kosicka-Noworzyń K, Brunetti L, Kagan L. Sheng YH, et al. Among authors: kosicka noworzyn k. J Pharm Biomed Anal. 2024 Sep 15;248:116259. doi: 10.1016/j.jpba.2024.116259. Epub 2024 Jun 2. J Pharm Biomed Anal. 2024. PMID: 38870837 Free article.

5

Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in Urine.

Abouzid M, Kosicka-Noworzyń K, Karaźniewicz-Łada M, Rao P, Modi N, Xie YL, Heysell SK, Główka A, Kagan L. Abouzid M, et al. Among authors: kosicka noworzyn k. Molecules. 2024 Jan 9;29(2):337. doi: 10.3390/molecules29020337. Molecules. 2024. PMID: 38257250 Free PMC article.

6

New approach to rifampicin stability and first-line anti-tubercular drug pharmacokinetics by UPLC-MS/MS.

Karaźniewicz-Łada M, Kosicka-Noworzyń K, Rao P, Modi N, Xie YL, Heysell SK, Kagan L. Karaźniewicz-Łada M, et al. Among authors: kosicka noworzyn k. J Pharm Biomed Anal. 2023 Oct 25;235:115650. doi: 10.1016/j.jpba.2023.115650. Epub 2023 Aug 15. J Pharm Biomed Anal. 2023. PMID: 37597382 Free PMC article.

7

Low on-treatment levels of serum soluble CD8 (sCD8) predict better outcomes in advanced non-small cell lung cancer patients treated with atezolizumab.

Siemiątkowska A, Bryl M, Kosicka-Noworzyń K, Tvrdoň J, Gołda-Gocka I, Główka FK. Siemiątkowska A, et al. Among authors: kosicka noworzyn k. Cancer Immunol Immunother. 2023 Jun;72(6):1853-1863. doi: 10.1007/s00262-023-03377-8. Epub 2023 Jan 23. Cancer Immunol Immunother. 2023. PMID: 36688998 Free PMC article.

8

Serum sCD25 Protein as a Predictor of Lack of Long-Term Benefits from Immunotherapy in Non-Small Cell Lung Cancer: A Pilot Study.

Siemiątkowska A, Bryl M, Kosicka-Noworzyń K, Tvrdoň J, Gołda-Gocka I, Barinow-Wojewódzki A, Główka FK. Siemiątkowska A, et al. Among authors: kosicka noworzyn k. Cancers (Basel). 2021 Jul 23;13(15):3702. doi: 10.3390/cancers13153702. Cancers (Basel). 2021. PMID: 34359602 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters